The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Recent progress in the battle between oncolytic viruses and tumours
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5
Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt-Jones, E. A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L., & Finberg, R. W. (1997) · Science · doi:10.1126/science.275.5304.1320 · Cited by 3,102
Khuri, F. R., Nemunaitis, J., Ganly, I., Arseneau, J., Tannock, I. F., Romel, L., Gore, M., Ironside, J., MacDougall, R. H., Heise, C., et al. (2000) · Nature Medicine · doi:10.1038/78638 · Cited by 1,101
Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant
Martuza, R. L., Malick, A., Markert, J. M., Ruffner, K. L., & Coen, D. M. (1991) · Science · doi:10.1126/science.1851332 · Cited by 1,050
The human CD46 molecule is a receptor for measles virus (Edmonston strain)
Dörig, R. E., Marcil, A., Chopra, A., & Richardson, C. D. (1993) · Cell · doi:10.1016/0092-8674(93)80071-l · Cited by 1,033
Markert, J. M., Medlock, M. D., Rabkin, S. D., Gillespie, G. Y., Todo, T., Hunter, W. D., Palmer, C. A., Feigenbaum, F., Tornatore, C., Tufaro, F., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301205 · Cited by 976
Heise, C., Sampson-Johannes, A., Williams, A., Mccormick, F., Von Hoff, D. D., & Kirn, D. H. (1997) · Nature Medicine · doi:10.1038/nm0697-639 · Cited by 940
Functional classification of interferon-stimulated genes identified using microarrays
de Veer, M. J., Holko, M., Frevel, M., Walker, E., Der, S., Paranjape, J. M., Silverman, R. H., & Williams, B. R. G. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.6.912 · Cited by 900
The roles of IFNγ in protection against tumor development and cancer immunoediting
Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00038-7 · Cited by 899
Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus
Naniche, D., Varior-Krishnan, G., Cervoni, F., Wild, T. F., Rossi, B., Rabourdin-Combe, C., & Gerlier, D. (1993) · Journal of Virology · doi:10.1128/jvi.67.10.6025-6032.1993 · Cited by 853
Takaoka, A., Hayakawa, S., Yanai, H., Stoiber, D., Negishi, H., Kikuchi, H., Sasaki, S., Imai, K., Shibue, T., Honda, K., et al. (2003) · Nature · doi:10.1038/nature01850 · Cited by 847
Stojdl, D. F., Lichty, B. D., tenOever, B. R., Paterson, J. M., Power, A. T., Knowles, S., Marius, R., Reynard, J., Poliquin, L., Atkins, H., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00241-1 · Cited by 842
Self-citationApoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis
Chawla-Sarkar, M., Lindner, D. J., Liu, Y.-F., Williams, B. R., Sen, G. C., Silverman, R. H., & Borden, E. C. (2003) · Apoptosis · doi:10.1023/a:1023668705040 · Cited by 829
Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas
Mineta, T., Rabkin, S. D., Yazaki, T., Hunter, W. D., & Martuza, R. L. (1995) · Nature Medicine · doi:10.1038/nm0995-938 · Cited by 822
Stojdl, D. F., Lichty, B., Knowles, S., Marius, R., Atkins, H., Sonenberg, N., & Bell, J. C. (2000) · Nature Medicine · doi:10.1038/77558 · Cited by 815
Self-citationDmitriev, I., Krasnykh, V., Miller, C. R., Wang, M., Kashentseva, E., Mikheeva, G., Belousova, N., & Curiel, D. T. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9706-9713.1998 · Cited by 767
He, B., Gross, M., & Roizman, B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.3.843 · Cited by 751
Immune responses to gene therapy vectors: influence on vector function and effector mechanisms
Bessis, N., GarciaCozar, F. J., & Boissier, M.-C. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302364 · Cited by 633
A critical function for type I interferons in cancer immunoediting
Dunn, G. P., Bruce, A. T., Sheehan, K. C. F., Shankaran, V., Uppaluri, R., Bui, J. D., Diamond, M. S., Koebel, C. M., Arthur, C., White, J. M., et al. (2005) · Nature Immunology · doi:10.1038/ni1213 · Cited by 605
Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway
Vergnolle, N., Bunnett, N. W., Sharkey, K. A., Brussee, V., Compton, S. J., Grady, E. F., Cirino, G., Gerard, N., Basbaum, A. I., Andrade-Gordon, P., et al. (2001) · Nature Medicine · doi:10.1038/89945 · Cited by 465
Chiocca, E. A., Abbed, K. M., Tatter, S., Louis, D. N., Hochberg, F. H., Barker, F., Kracher, J., Grossman, S. A., Fisher, J. D., Carson, K., et al. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.07.021 · Cited by 436
Targeting mTOR signaling for cancer therapy
Huang, S. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00071-7 · Cited by 436
Targeted gene delivery by tropism-modified adenoviral vectors
Douglas, J. T., Rogers, B. E., Rosenfeld, M. E., Michael, S. I., Feng, M., & Curiel, D. T. (1996) · Nature Biotechnology · doi:10.1038/nbt1196-1574 · Cited by 428
Pecora, A. L., Rizvi, N., Cohen, G. I., Meropol, N. J., Sterman, D., Marshall, J. L., Goldberg, S., Gross, P., O’Neil, J. D., Groene, W. S., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.042 · Cited by 385
Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity
O'Shea, C. C., Johnson, L., Bagus, B., Choi, S., Nicholas, C., Shen, A., Boyle, L., Pandey, K., Soria, C., Kunich, J., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.11.012 · Cited by 372
McCart, J. A., Ward, J. M., Lee, J., Hu, Y., Alexander, H. R., Libutti, S. K., Moss, B., & Bartlett, D. L. (2001) · PubMed · Cited by 366
Intergeneric poliovirus recombinants for the treatment of malignant glioma
Gromeier, M., Lachmann, S., Rosenfeld, M. R., Gutin, P. H., & Wimmer, E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6803 · Cited by 363
Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma
Mastrangelo, M. J., Maguire, H. C., Eisenlohr, L. C., Laughlin, C. E., Monken, C. E., McCue, P. A., Kovatich, A. J., & Lattime, E. C. (1999) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700066 · Cited by 353
Harrow, S., Papanastassiou, V, Harland, J., Mabbs, R., Petty, R., Fraser, M., Hadley, D., Patterson, J., Brown, S. M., & Rampling, R. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302289 · Cited by 342
Ikeda, K., Ichikawa, T., Wakimoto, H., Silver, J. S., Deisboeck, T. S., Finkelstein, D., Harsh, G. R., Louis, D. N., Bartus, R. T., Hochberg, F. H., et al. (1999) · Nature Medicine · doi:10.1038/11320 · Cited by 339
Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies
Fisher, K., Stallwood, Y., Green, N., Ulbrich, K., Mautner, V, & Seymour, L. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301389 · Cited by 316
High CD46 Receptor Density Determines Preferential Killing of Tumor Cells by Oncolytic Measles Virus
Anderson, B. D., Nakamura, T., Russell, S. J., & Peng, K.-W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0884 · Cited by 315
Lin, R., Noyce, R. S., Collins, S. E., Everett, R. D., & Mossman, K. L. (2004) · Journal of Virology · doi:10.1128/jvi.78.4.1675-1684.2004 · Cited by 269
Intravascular adenoviral agents in cancer patients: Lessons from clinical trials
Reid, T., Warren, R., & Kirn, D. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700539 · Cited by 258
Rescue and propagation of fully retargeted oncolytic measles viruses
Nakamura, T., Peng, K.-W., Harvey, M., Greiner, S., Lorimer, I. A. J., James, C. D., & Russell, S. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1060 · Cited by 252
Reid, T., Galanis, E., Abbruzzese, J., Sze, D., Andrews, J., Romel, L., Hatfield, M., Rubin, J., & Kirn, D. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301512 · Cited by 243
Newcastle Disease Virus V Protein Is a Determinant of Host Range Restriction
Park, M.-S., García-Sastre, A., Cros, J. F., Basler, C. F., & Palese, P. (2003) · Journal of Virology · doi:10.1128/jvi.77.17.9522-9532.2003 · Cited by 243
Xia, Z.-J., Chang, J.-H., Zhang, L., et al. (2004) · PubMed · Cited by 241
Oncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1
Farassati, F., Yang, A.-D., & Lee, P. W. K. (2001) · Nature Cell Biology · doi:10.1038/35087061 · Cited by 236
VSV Disrupts the Rae1/mrnp41 mRNA Nuclear Export Pathway
Faria, P. A., Chakraborty, P., Levay, A., Barber, G. N., Ezelle, H. J., Enninga, J., Arana, C., van Deursen, J., & Fontoura, B. M. A. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.11.023 · Cited by 235
Croyle, M. A., Chirmule, N., Zhang, Y., & Wilson, J. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.10.4792-4801.2001 · Cited by 229
Targets and mechanisms for the regulation of translation in malignant transformation
Clemens, M. J. (2004) · Oncogene · doi:10.1038/sj.onc.1207544 · Cited by 223
Shayakhmetov, D. M., Li, Z.-Y., Ni, S., & Lieber, A. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5368-5381.2004 · Cited by 210
Mastrangeli, A., Harvey, B.-G., Yao, J., Wolff, G., Kovesdi, I., Crystal, R. G., & Falck-Pedersen, E. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.1-79 · Cited by 204
Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus
Green, N. K., Herbert, C. W., Hale, S. J., Hale, A. B., Mautner, V, Harkins, R., Hermiston, T., Ulbrich, K., Fisher, K. D., & Seymour, L. W. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302295 · Cited by 204
Lee, C.-J., Liao, C.-L., & Lin, Y.-L. (2005) · Journal of Virology · doi:10.1128/jvi.79.13.8388-8399.2005 · Cited by 197
Norman, K. L., Hirasawa, K., Yang, A.-D., Shields, M. A., & Lee, P. W. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404310101 · Cited by 189
Bjornsti, M.-A., & Houghton, P. J. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.027 · Cited by 181
Disruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrier
Wang, F., Ma, Y., Barrett, J. W., Gao, X., Loh, J., Barton, E., Virgin, H. W., & McFadden, G. (2004) · Nature Immunology · doi:10.1038/ni1132 · Cited by 180
Balachandran, S., Porosnicu, M., & Barber, G. N. (2001) · Journal of Virology · doi:10.1128/jvi.75.7.3474-3479.2001 · Cited by 174
Systemic reovirus therapy of metastatic cancer in immune-competent mice.
Hirasawa, K., Nishikawa, S. G., Norman, K. L., Coffey, M. C., Thompson, B., Yoon, C., Waisman, D. M., & Lee, P. W. K. (2003) · PubMed · Cited by 173
Defective translational control facilitates vesicular stomatitis virus oncolysis
Balachandran, S., & Barber, G. N. (2004) · Cancer Cell · doi:10.1016/s1535-6108(03)00330-1 · Cited by 171
Vesicular Stomatitis Virus (VSV) Therapy of Tumors
Balachandran, S., & Barber, G. N. (2000) · IUBMB Life · doi:10.1080/15216540050212169 · Cited by 162
Jooss, K., Yang, Y., & Wilson, J. M. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.13-1555 · Cited by 160
Holterman, L., Vogels, R., van der Vlugt, R., Sieuwerts, M., Grimbergen, J. M., Kaspers, J., Geelen, E., van der Helm, E., Lemckert, A. A. C., Gillissen, G. F., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.13207-13215.2004 · Cited by 148
Kaufman, H. L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24624 · Cited by 146
Attenuated, Replication-Competent Herpes Simplex Virus Type 1 Mutant G207: Safety Evaluation in Mice
Sundaresan, P., Hunter, W. D. G., Martuza, R. L., & Rabkin, S. D. (2000) · Journal of Virology · doi:10.1128/jvi.74.8.3832-3841.2000 · Cited by 140
Ohno, S., Ono, N., Takeda, M., Takeuchi, K., & Yanagi, Y. (2004) · Journal of General Virology · doi:10.1099/vir.0.80308-0 · Cited by 130
Nilsson, M., Ljungberg, J., Richter, J., Kiefer, T., Magnusson, M., Lieber, A., Widegren, B., Karlsson, S., & Fan, X. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.543 · Cited by 129
Benencia, F., Courreges, M. C., Conejo-Garcia, J. R., Mohamed-Hadley, A. A., Zhang, L., Buckanovich, R. J., Carroll, R. H., Fraser, N. W., & Coukos, G. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.03.026 · Cited by 127
Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses
Ahmed, M., Cramer, S. D., & Lyles, D. S. (2004) · Virology · doi:10.1016/j.virol.2004.08.039 · Cited by 127
Smith, T. A., White, B. D., Gardner, J. M., Kaleko, M., & McClelland, A. (1996) · PubMed · Cited by 126
Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker
Peng, K.-W., Donovan, K. A., Schneider, U., Cattaneo, R., Lust, J. A., & Russell, S. J. (2003) · Blood · doi:10.1182/blood-2002-07-2195 · Cited by 124
Lü, W. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i24.3634 · Cited by 124
Wakimoto, H., Fulci, G., Tyminski, E., & Chiocca, E. A. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302143 · Cited by 121
Nakamura, T., Peng, K.-W., Vongpunsawad, S., Harvey, M. E., Mizuguchi, H., Hayakawa, T., Cattaneo, R., & Russell, S. J. (2004) · Nature Biotechnology · doi:10.1038/nbt942 · Cited by 118
Oncolytic Viruses: Clinical Applications as Vectors for the Treatment of Malignant Gliomas
Shah, A. C., Benos, D. J., Gillespie, G. Y., & Markert, J. M. (2003) · Journal of Neuro-Oncology · doi:10.1023/b:neon.0000003651.97832.6c · Cited by 116
Chung, R. Y., Saeki, Y., & Chiocca, E. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7556-7564.1999 · Cited by 115
O’Shea, C. C., Soria, C. T., Bagus, B., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.009 · Cited by 112
Sailaja, G. S., HogenEsch, H., North, A., Hays, J., & Mittal, S. K. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301858 · Cited by 110
Recombinant Measles Viruses Efficiently Entering Cells through Targeted Receptors
Schneider, U., Bullough, F. J., Vongpunsawad, S., Russell, S. J., & Cattaneo, R. (2000) · Journal of Virology · doi:10.1128/jvi.74.21.9928-9936.2000 · Cited by 110
Sana, T. R., Janatpour, M. J., Sathe, M., McEvoy, L. M., & McClanahan, T. K. (2005) · Cytokine · doi:10.1016/j.cyto.2004.11.003 · Cited by 106
Ilan, Y., Jona, V., Sengupta, K., Davidson, A., Horwitz, M. S., Roy-Chowdhury, N., & Roy‐Chowdhury, J. (1997) · Hepatology · doi:10.1002/hep.510260422 · Cited by 105
Eukaryotic Translation Initiation Factor 4E Activity Is Modulated by HOXA9 at Multiple Levels
Topisirović, I., Kentsis, A., Perez, J. M., Guzmán, M. L., Jordan, C. T., & Borden, K. L. B. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.3.1100-1112.2005 · Cited by 104
Development and Assessment of Human Adenovirus Type 11 as a Gene Transfer Vector
Stone, D., Ni, S., Li, Z.-Y., Gaggar, A., Paolo, N. C. D., Feng, Q., Sandig, V., & Lieber, A. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.5090-5104.2005 · Cited by 102
Mulvey, M. A., Poppers, J., Sternberg, D., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.20.10917-10928.2003 · Cited by 100
Inhibition of PKR by vaccinia virus: role of the N- and C-terminal domains of E3L
Langland, J., & Jacobs, B. L. (2004) · Virology · doi:10.1016/j.virol.2004.03.012 · Cited by 99
Complexes of poliovirus serotypes with their common cellular receptor, CD155
He, Y., Mueller, S., Chipman, P. R., Bator, C. M., Peng, X., Bowman, V. D., Mukhopadhyay, S., Wimmer, E., Kuhn, R. J., & Rossmann, M. G. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4827-4835.2003 · Cited by 98
Eto, Y., Gao, J., Sekiguchi, F., Kurachi, S., Katayama, K., Maeda, M., Kawasaki, K., Mizuguchi, H., Hayakawa, T., Tsutsumi, Y. M., et al. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.699 · Cited by 96
Reboredo, M., Greaves, R. F., & Hahn, G. (2004) · Journal of General Virology · doi:10.1099/vir.0.80379-0 · Cited by 88
Perkins, D. J., & Barber, G. N. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.5.2025-2040.2004 · Cited by 86
Oncolysis of vascular malignant human melanoma tumors by Coxsackievirus A21
Au, G. G., Lindberg, A., Barry, R. D., et al. (2005) · International Journal of Oncology · doi:10.3892/ijo.26.6.1471 · Cited by 83
Liu, T., Halldén, G., Wang, Y., Brooks, G., Francis, J., Lemoine, N., & Kirn, D. H. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.03.017 · Cited by 82
Resistance to viral infection of super p53 mice
Muñoz‐Fontela, C., García, M. Á., Garcı́a-Cao, I., Collado, M., Arroyo, J., Estéban, M., Serrano, M., & Rivas, C. (2005) · Oncogene · doi:10.1038/sj.onc.1208477 · Cited by 78
Hahm, B., Arbour, N., Naniche, D., Homann, D., Manchester, M., & Oldstone, M. B. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.6.3505-3515.2003 · Cited by 77
Development of Replication-Defective Herpes Simplex Virus Vectors
Krisky, D. M., Marconi, P., Goins, W. F., & Glorioso, J. C. (2003) · Humana Press eBooks · doi:10.1385/0-89603-484-4:79 · Cited by 71
RNA sensors: novel regulators of gene expression
Kaempfer, R. O. R. (2003) · EMBO Reports · doi:10.1038/sj.embor.7400005 · Cited by 70
Oncolytic activities of approved mumps and measles vaccines for therapy of ovarian cancer
Myers, R. M., Greiner, S. M., Harvey, M. E., Soeffker, D., Frenzke, M. E., Abraham, K. G., SHAW, A. R., Rozenblatt, S., Federspiel, M. J., Russell, S. J., et al. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700823 · Cited by 68
Two PKR inhibitor HCV proteins correlate with early but not sustained response to interferon
Gerotto, M., Pero, F. D., Pontisso, P., Noventa, F., Gatta, A., & Alberti, A. (2000) · Gastroenterology · doi:10.1053/gast.2000.20230 · Cited by 61
Hummel, J., Safroneeva, E., & Mossman, K. L. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.07.533 · Cited by 55
Anti-apoptotic and oncogenic properties of the dsRNA-binding protein of vaccinia virus, E3L
García, M. Á., Guerra, S., Gil, J., Jiménez, V., & Estéban, M. (2002) · Oncogene · doi:10.1038/sj.onc.1206036 · Cited by 54
Ochiai, H., Moore, S. A., Archer, G. E., Okamura, T., Chewning, T. A., Marks, J. R., Sampson, J. H., & Gromeier, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0694 · Cited by 52
Cellular receptor interactions of C-cluster human group A coxsackieviruses
Newcombe, N. G., Andersson, P. O., Johansson, E., Au, G. G., Lindberg, A., Barry, R. D., & Shafren, D. R. (2003) · Journal of General Virology · doi:10.1099/vir.0.19329-0 · Cited by 52
Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectors
Borovjagin, A. V., Krendelchtchikov, A., Ramesh, N., Yu, D., Douglas, J. T., & Curiel, D. T. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700806 · Cited by 50
Shelton, J. G., Steelman, L. S., Abrams, S. L., Bertrand, F. E., Franklin, R. A., McMahon, M., & McCubrey, J. A. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.5.1009 · Cited by 47
Khabar, K. S. A., Al‐Haj, L., Al-Zoghaibi, F., Marie, M., Dhalla, M., Polyak, S. J., & Williams, B. R. G. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.07.065 · Cited by 37
Wright, C. W., Means, J. C., Penabaz, T., & Clem, R. J. (2005) · Virology · doi:10.1016/j.virol.2005.02.007 · Cited by 28
Therapeutic Efficacy of G207 in a Novel Peripheral Nerve Sheath Tumor Model
Mashour, G. A., Moulding, H. D., Chalavi, A., Khan, G., Rabkin, S. D., Martuza, R. L., Driever, P. H., & Kurtz, A. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7641 · Cited by 22
Fukuhara, H., Hayashi, Y., Yamamoto, N., Fukui, T., Nishikawa, M., Mitsudo, K., Tohnai, I., Ueda, M., Mizuno, M., & Yoshida, J. (2003) · Oral Oncology · doi:10.1016/s1368-8375(03)00047-2 · Cited by 21
The Human Poliovirus Receptor: Receptor‐Virus Interaction and Parameters of Disease Specificity
Gromeier, M., Lu, H., Bernhardt, G., Harber, J. J., Bibb, J. A., & Wimmer, E. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb27528.x · Cited by 13
Cited by
Shape effects of filaments versus spherical particles in flow and drug delivery
Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., & Discher, D. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.70 · Cited by 2,565
History of Oncolytic Viruses: Genesis to Genetic Engineering
Kelly, E., & Russell, S. J. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300108 · Cited by 763
The good viruses: viral mutualistic symbioses
Roossinck, M. J. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2491 · Cited by 620
Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans
Breitbach, C. J., Burke, J., Jonker, D., Stephenson, J., Haas, A. R., Chow, L. Q. M., Nieva, J., Hwang, T.-H., Moon, A., Patt, R., et al. (2011) · Nature · doi:10.1038/nature10358 · Cited by 551
Self-citationPark, B.-H., Hwang, T., Liu, T.-C., Sze, D. Y., Kim, J.-S., Kwon, H.-C., Oh, S. Y., Han, S.-Y., Yoon, J.-H., Hong, S.-H., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70107-4 · Cited by 521
Self-citation
Metadata
- Authors
- Parato, K. A., Senger, D., Forsyth, P. A. J., & Bell, J. C.
- Venue
- Nature Reviews Cancer
- Published
- 2005-11-18
- Volume
- 5
- Issue
- 12
- Pages
- 965-976
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2090732350
- Cited by
- 536
- References
- 99
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.